Advertisement

Supply Chain



Pharmaceutical giant Gilead Sciences will purchase Cell Design Labs, a California biotechnology company for up to $567 million in a move to advance development of cancer drugs, according to Reuters.

Advertisement

Most Read

Advertisement
Advertisement